News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dionex (DNEX) Enters Into Agreement With ESA Biosciences to Acquire the Assets of ESA Biosciences Tools Business Unit; Dionex Anticipates the Transaction will Generate Additional Revenue of $12-$15 Million


9/16/2009 8:52:57 AM

Bookmark and Share

SUNNYVALE, Calif., Sept. 16, 2009 (GLOBE NEWSWIRE) -- Dionex Corporation (Nasdaq:DNEX), a leading provider of innovative liquid chromatography analysis systems, has entered into an Asset Purchase Agreement with ESA Biosciences, a wholly owned subsidiary of Magellan Biosciences, Inc., to purchase ESA Biosciences HPLC products, HPLC clinical assays, laboratory services and related assets.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES